Metabolic Phospholipid Labeling via Copper-Free Click Chemistry

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The cell biology of phospholipids is not well understood, and there is a need for methods to metabolically label and visualize phospholipids in cells for better understanding of their biosynthesis and distribution.

Innovation Solution

The method involves forming alkynyl- or azido-functional analogs of phospholipid precursors by reacting them with alkyne or azide moieties, which are then incorporated into cells and detected using copper-free click chemistry, allowing for high-resolution microscopic imaging of labeled phospholipids.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional phospholipid labeling methods are used, then phospholipids can be detected, but the resolution and sensitivity of imaging is insufficient for high-resolution microscopic visualization

Engineering Contradiction:
Improveimaging resolutionVSAvoidlabeling method complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The labeling process is divided into two distinct stages: first, metabolic incorporation of non-fluorescent precursors into phospholipids within cells; second, post-incubation click chemistry reaction to attach fluorescent probes. This segmentation allows each stage to be optimized independently, achieving high imaging resolution without overwhelming complexity in a single step.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The phospholipid precursors are pre-loaded into cells through metabolic pathways before the actual labeling reaction occurs. This preliminary action enables the phospholipids to be naturally distributed and positioned within cellular structures, ensuring that subsequent fluorescent labeling occurs at the correct locations for high-resolution imaging.

Inventive Principle:
Principle #10Preliminary action

2Quantity of substance

If metabolic labeling with analogs is performed, then phospholipid distribution can be visualized, but the labeling efficiency and incorporation rate into endogenous phospholipids is low

Engineering Contradiction:
Improvelabeling efficiencyVSAvoidbiosynthesis rate
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

Non-fluorescent phospholipid precursors serve as intermediaries that are naturally metabolized and incorporated into endogenous phospholipids through cellular metabolic pathways. These intermediaries bridge the gap between external labeling agents and internal phospholipid structures, enabling efficient incorporation without disrupting normal biosynthesis rates.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The chemical structure of phospholipid precursors is modified to include reactive handles (azide or alkyne groups) while maintaining their biological activity and metabolic compatibility. This parameter change allows the precursors to be recognized and processed by cellular enzymes at near-natural incorporation rates, subsequently enabling efficient fluorescent labeling through click chemistry.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If fluorescent probes are attached to phospholipids, then visualization is achieved, but the labeling process may interfere with normal phospholipid metabolism and function

Engineering Contradiction:
Improvemetabolic normalityVSAvoidlabeling process simplicity
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The fluorescent probe attachment step is extracted and performed separately after phospholipid incorporation has occurred. By separating the metabolic incorporation phase from the fluorescent labeling phase, the natural phospholipid metabolism remains undisturbed during the critical incorporation stage, while labeling efficiency is maximized in the subsequent isolated step.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

Non-fluorescent precursors are used as disposable intermediaries that perform their labeling function and then can be selectively removed or degraded. These temporary carriers enable the labeling process without requiring complex reversible systems, simplifying the overall approach while maintaining metabolic compatibility.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

4Reliability

If copper-free click chemistry is used for labeling, then cell viability is maintained, but the reaction efficiency and labeling speed is reduced compared to copper-catalyzed methods

Engineering Contradiction:
Improvecell viabilityVSAvoidreaction rate
Core Design Contradiction:
ReliabilityVSSpeed

Solution Approach 1:

The reaction conditions are optimized by changing parameters such as probe concentration, incubation time, and buffer composition to compensate for the slower reaction rate of copper-free click chemistry. These parameter adjustments maintain cell viability while achieving sufficient labeling efficiency for high-resolution imaging applications.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables effective metabolic labeling and visualization of phospholipids in cells, facilitating the study of their biosynthesis, distribution, and potential disorders such as cancer or neurological conditions, and aiding in drug discovery by assessing the impact of compounds on phospholipid biosynthesis.

Implementation Method 1

contacting the cells with an azide or alkyne compound, respectively, bearing a detectable label under conditions sufficient to allow the azide moiety to react with the alkynyl or azido moiety, to form a 1,2,3-triazole

Methodology Applied
Scientific EffectClick chemistry: Chemical Bonding

Data Source

PatentUS8987514B2Compositions and methods for labeling and imaging phospholipids
Publication Date: 2015.03.24 PRESIDENT & FELLOWS OF HARVARD COLLEGE
  • US8987514B2 patent drawing
  • US8987514B2 patent drawing
  • US8987514B2 patent drawing

AI summary

The present invention provides a method to label phospholipids in vivo based on the metabolic incorporation of an alkynyl- or azido-labeled metabolic precursor into phospholipids. The resulting phospholipids have alkynyl or azido moieties, which, upon reaction with a labeled azide or alkyne, respectively, form labeled compounds that can be visualized using optical or electron microscopy with high sensitivity and spatial resolution in cells or tissue. The present method provides a valuable tool for imaging phospholipid synthesis, turnover and subcellular localization in cultured cells as well as in animals.